文献速递肾移植慢性肾脏病

新发肾移植受者的骨密度、骨转换标志物与骨折事件

Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients.
PubMed 文献 · Kidney Int · 2019-03-04

这项前瞻性观察研究纳入518例成人新发肾移植受者,移植前检测骨转换标志物,移植后14天内用双能X线吸收法测面积骨密度(aBMD)。中位随访5.2年,38例发生脆性骨折,发生率14.1/1000人年;低aBMD与骨折事件独立相关,而移植时PTH及骨转换标志物未能预测骨折。

要点

  • 新发肾移植受者中aBMD普遍偏低,77%股骨颈存在骨量减少或骨质疏松。
  • 低aBMD与移植后脆性骨折事件独立相关,可辅助风险分层。
  • 移植时PTH及骨转换标志物未能预测后续骨折事件。

核心结论

  • 新发肾移植受者aBMD偏低,与骨转换呈负相关,并能预测移植后脆性骨折事件。
  • 移植时PTH和骨转换标志物未能预测后续骨折事件。

研究设计与样本

  • 前瞻性观察研究,纳入518例成人新发肾移植受者。
  • 移植前采集血样检测PTH、FGF23、硬化素、骨化二醇、骨化三醇及骨转换标志物。
  • 移植后14天内于多个骨骼部位测量aBMD,中位随访5.2年。

主要发现

  • 骨转换标志物与所有骨骼部位aBMD呈负相关。
  • 低aBMD和低PTH与移植时脆性骨折史相关,独立于年龄、性别和合并症。
  • 随访期间38例发生脆性骨折,发生率为14.1/1000人年。
  • 髋部和腰椎低aBMD与骨折事件相关,独立于经典决定因素(包括骨折史)。

临床怎么用

  • 对新发肾移植受者可在移植后早期测量髋部和腰椎aBMD以评估骨折风险。
  • 低aBMD提示骨折高风险,可考虑纳入风险分层和随访管理。
  • 不宜仅依据移植时PTH或骨转换标志物预测骨折风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Kidney transplant recipients are at increased risk of fractures. This prospective observational study investigated whether areal bone mineral density (aBMD) as assessed by dual-energy x-ray absorptiometry can predict incident fragility fractures in de novo kidney transplant recipients and whether bone turnover markers increase diagnostic accuracy. Parameters of bone mineral metabolism including parathyroid hormone (PTH), fibroblast growth factor 23, sclerostin, calcidiol and calcitriol, and bone turnover markers were assessed in blood samples collected immediately prior to kidney transplantation in 518 adult recipients. aBMD was measured at several skeletal sites within 14 days posttransplant. Thirty patients had a history of a fragility fracture at the time of transplantation, and osteopenia or osteoporosis at the femoral neck was observed in 77%. Bone turnover markers were inversely correlated with aBMD at all skeletal sites. Low aBMD and low PTH were associated with history of fragility fracture at the time of transplantation, independent of age, gender, and comorbidity. During a median post-transplant follow-up of 5.2 years, 38 patients sustained a fragility fracture, corresponding to a fracture incidence of 14.1 per 1000 person-years. Low aBMD at the hip and lumbar spine were associated with incident fractures, independent of classical determinants, including history of fracture. PTH and bone turnover markers at the time of transplantation failed to predict incident fractures. In conclusion, aBMD is low, correlates inversely with bone turnover, and predicts incident fractures in de novo kidney transplant recipients.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Evenepoel P, Claes K, Meijers B, et al. Bone mineral density, bone turnover markers, and incident fractures in de novo kidney transplant recipients. Kidney Int. 2019. PMID: 30922664. doi:10.1016/j.kint.2018.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。